Page last updated: 2024-10-21

ethylisopropylamiloride and Cancer of Pancreas

ethylisopropylamiloride has been researched along with Cancer of Pancreas in 2 studies

ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhu, BY1
Shang, BY1
Du, Y1
Li, Y1
Li, L1
Xu, XD1
Zhen, YS1
Hayashi, Y1
Katayama, K1
Togawa, T1
Kimura, T1
Yamaguchi, A1

Other Studies

2 other studies available for ethylisopropylamiloride and Cancer of Pancreas

ArticleYear
A new HDAC inhibitor cinnamoylphenazine shows antitumor activity in association with intensive macropinocytosis.
    Oncotarget, 2017, Feb-28, Volume: 8, Issue:9

    Topics: A549 Cells; Amiloride; Animals; Blotting, Western; Cell Line, Tumor; Cinnamates; Colonic Neoplasms;

2017
Effects of bafilomycin A1, a vacuolar type H+ ATPase inhibitor, on the thermosensitivity of a human pancreatic cancer cell line.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2006, Volume: 22, Issue:4

    Topics: Amiloride; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Temperature Regulation; Cel

2006